SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-004686
Filing Date
2013-10-10
Accepted
2013-10-10 16:52:45
Documents
7
Period of Report
2013-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AKORN, INC. 8-K a50726231.htm 8-K 34591
2 EXHIBIT 3.1 a50726231ex3_1.htm EX-3.1 4945
3 EXHIBIT 3.2 a50726231ex3_2.htm EX-3.2 67331
4 EXHIBIT 10.1 a50726231ex10_1.htm EX-10.1 175607
5 EXHIBIT 10.2 a50726231ex10_2.htm EX-10.2 59496
6 EXHIBIT 10.3 a50726231ex10_3.htm EX-10.3 33754
7 GRAPHIC emla.jpg GRAPHIC 5902
  Complete submission text file 0001157523-13-004686.txt   385314
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 131146371
SIC: 2834 Pharmaceutical Preparations